Navigation Links
Tip sheet for the Annals of Internal Medicine, April 15, 2008, issue
Date:4/14/2008

1. Testosterone Spray Improves Sexual Satisfaction Slightly in Premenopausal Women But So Does Placebo; Editorial Says Treat Women Conventionally

A study that randomized 261 women aged 35 to 46 with self-reported low libido and low serum free testosterone levels to a group that received one of three different doses of a testosterone spray or placebo daily for 16 weeks found that all groups -- including those taking placebo--reported increased frequency of sexually satisfying events (Article, p. 569).

The difference between testosterone spray and placebo was statistically significant only for the middle dose of testosterone.

Overall, 81 percent to 86 percent of women in the active treatment groups and 70 percent of the women in the placebo group reported adverse events. The most common event in the treatment group was hair growth on the abdomen, where the testosterone was sprayed.

An editorial writer says that just because testosterone levels and womens libidos may decline as women age does not mean that lack of testosterone explains sexual dissatisfaction (Editorial, p. 620).

We do not have a fully satisfactory rationale for testosterone therapy, the writer says, and there is also a lack of long-term safety data. Rather than prescribe testosterone, the writer advises primary physicians to address womens mental health and relationship issues, sexual dysfunction in the partner and treat problems by conventional therapy, such as cognitive behavioral therapy, sex therapy, and psychotherapy.


2. Risks and Benefits of Buying Prescription Drugs from Foreign Countries

Buying imported prescription drugs is legal in some cases, but even when the drug is cheaper than a U.S. brand-name drug, it may not be a wise purchase, say authors of a paper on the international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients (Medicine and Public Issues, p. 614).

Authors posit four guidelines for patients, physicians and policymakers for importation of prescription drugs.

However, the safest way to control U.S. drug prices is by promoting consumer demand for and appropriate prescription of domestic generic drugs, they say.


3. Comprehensive Strategy Needed to Control Gonorrhea Epidemic

Incidence of Neisseria gonorrhoeae in the United States declined markedly from 1975 to 1997 and has remained relatively stable over the past decade at about 120.9 cases per 100,000 population (Perspective, p. 606).

However, rates of gonorrhea remain high in the South and among African Americans, adolescents, young adults, and men who have sex with men, and infection rates are rising. Further, the disease has serous implications for reproductive health and health costs; and treatment options have narrowed as gonorrhea has become resistant to many drugs; (currently, gonorrhea treatment options come from a single class of antimicrobials -- cephalosporins).

Authors say that in addition to developing and providing effective antimicrobial drugs, a comprehensive program to control gonorrhea must include screening people at risk for infection, surveillance for resistance, secondary screening and treatment of sex partners, and stimulating investment into research for new antimicrobials.


'/>"/>

Contact: Susan Anderson
sanderson@acponline.org
215-351-2653
American College of Physicians
Source:Eurekalert

Related medicine news :

1. NEWSWEEK: Media Lead Sheet/April 21, 2008 Issue (on newsstands Monday, April 14).
2. Annals of Internal Medicine tip sheet for April 1, 2008, issue
3. FEW Announces Legislative Goals for Remainder of 110th Congress; Delivers Fact Sheets to Legislators
4. NEWSWEEK: Media Lead Sheet/March 24, 2008 Issue (on newsstands Monday, March 17)
5. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
6. VoIP-PAL.com, Inc. (Pink Sheets: VPLM.PK - News) UPDATE: Announces First Award Recipient of TalkfortheCure(TM) Dollars
7. NEWSWEEK: Media Lead Sheet/March 3, 2008 Issue (on newsstands Monday, February 25)
8. Annals of Internal Medicine tip sheet for Feb. 5, 2008, issue
9. MedeFile Materially Strengthens Balance Sheet Through Equity Financing and Debt Conversion Totaling $4 Million
10. NEWSWEEK: Media Lead Sheet/February 4, 2008 Issue (on newsstands Monday, January 28)
11. NEWSWEEK: Media Lead Sheet/January 28, 2008 Issue (on newsstands Monday, January 21).
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... http://www.foodsthathealdaily.com , http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to ... of Water, Global Climate Change and Your Health on Voice America sponsored by ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back ... joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified ... The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April 30 ... Urgent Care Medicine will host industry leaders for the annual spring Convention & ... in the industry adapt to the issues currently affecting urgent care and on-demand ...
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer and ... communities. After Tina Howe joined the team, the Bill Howe brand was born and ... affordable rates, and giving back to the San Diego community in which they worked, ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... North East region. Côté has 20+ years of experience within the beauty industry, ... worked with an array of high-end cosmetic brands, retail brands and outlets in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ... ... rise from USD 20 Billion in 2015 to around USD 26 ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
Breaking Medicine Technology: